SFG
RMD icon

Strive Financial Group’s ResMed RMD Stock Holding History

Strive Financial Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.95K Hold
10
– – ﹤0.01% 647
2026
Q1 		$2K Hold
10
– – ﹤0.01% 658
2025
Q4 		$2.41K Buy
+10
New +$2.56K ﹤0.01% 562

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Strive Financial Group's RMD Position: Q2 2026 in Review

Strive Financial Group held its ResMed (RMD) position steady in Q2 2026 at 10 shares worth $1.95K. The position accounts for ﹤0.01% of the portfolio, ranked #647.

Strive Financial Group first reported a position in RMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.41K in Q4 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Strive Financial Group held 10 shares of ResMed worth $1.95K as of Q2 2026.
  • Strive Financial Group left its ResMed share count unchanged in Q2 2026.
  • ResMed made up ﹤0.01% of Strive Financial Group's portfolio in Q2 2026, its #647 holding.
  • Strive Financial Group first reported a position in ResMed in Q4 2025 and has held it in 3 quarters since.
  • Strive Financial Group's ResMed position peaked at $2.41K in Q4 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Strive Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.